期刊
NEONATOLOGY
卷 107, 期 4, 页码 277-282出版社
KARGER
DOI: 10.1159/000369955
关键词
Nebulization; Neonatal respiratory distress syndrome; Surfactant
类别
资金
- Chiesi Farmaceutici S.P.A., Parma, Italy
Background: It would be advantageous for the treatment of neonatal respiratory distress syndrome if effective amounts of surfactant could be delivered by nebulization. Objective: To investigate lung deposition and distribution of nebulized porcine surfactant using an investigational eFlow (R) neonatal nebulizer. Methods: While lying on one side, 1-day-old piglets inhaled 200 mg . kg(-1) of nebulized surfactant via mask, nasal prongs, or tracheal tube. The surfactant was diluted with normal saline to 40 mg . ml(-1) and labeled with (99m)technetium-labelled nanocolloid. Undiluted surfactant (80 mg . ml(-1)) was instilled tracheally in a fourth group. Each group had 8 animals. Lung deposition was measured by gamma scintigraphy, and deposition values were presented as a percentage of the nebulized or instilled dose. Results: The median lung deposition of inhaled surfactant was 5% (range 3-16) via mask, 14% (2-40) via prongs, and 45% (2556) via tracheal tube (p <0.05). It was 88% (71-96) with instillation. In all groups, the surfactant preferentially went to the dependent lung. Deposition ratios (upper lung/both lungs) were 0.32(0.13-0.58), 0.15 (0.05-0.58), 0.16 (0.11-0.23), and 0.08 (0.03-0.46). Conclusions: Using this nebulizer, the lung depositions of porcine surfactant were 45% via endotracheal tube and 14% via nasal-continuous positive airway pressure (prongs). These figures might be physiologically relevant, but still have to be confirmed in efficacy studies. (C) 2015 S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据